• Publications
  • Influence
Evaluation of the Impact of Migraine and Episodic Tension‐type Headache on the Quality of Life and Performance of a University Student Population
To determine the prevalence of migraine and episodic tension‐type headache among university students as well as its impact on academic performance and quality of life, a large number of university students with a history of migraine are surveyed. Expand
Symptoms of temporomandibular disorders in the population: an epidemiological study.
Individual symptoms, as well as a combination of TMD symptoms, are prevalent in the Brazilian urban population and are more frequent in women than in men and additional studies should focus on risk factors for and relevance for the sufferer. Expand
Intravenous Magnesium Sulphate in the Acute Treatment of Migraine Without Aura and Migraine with Aura. A Randomized, Double-Blind, Placebo-Controlled Study
The data support the idea that magnesium sulphate can be used for the treatment of all symptoms in migraine with aura, or as an adjuvant therapy for associated symptoms in patients with migraine without aura. Expand
Temporomandibular disorders, sleep bruxism, and primary headaches are mutually associated.
The association of sleep bruxism and painful TMD greatly increased the risk for episodic migraine, episodic tension-type headache, and especially for chronic migraine. Expand
Endothelial nitric oxide synthase haplotypes associated with aura in patients with migraine.
It is suggested that these two eNOS haplotypes affect the susceptibility to the presence of aura in patients with migraine. Expand
Migraine is the most prevalent primary headache in individuals with temporomandibular disorders.
TMD was associated with increased primary HA prevalence rates and migraine frequency was positively associated with TMD pain severity, and myofascial pain/arthralgia was the most common primary HA diagnosis in individuals with T MD. Expand
Intravenous chlorpromazine in the emergency department treatment of migraines: a randomized controlled trial.
Clinical and statistically significant improvement associated with CPZ is found in pain scores, nausea, photophobia, phonophobia, and need for rescue medication, all at 60 min, and in rate of recurrence at 24 h, both in patients with and without aura. Expand
Pressure pain threshold in the craniocervical muscles of women with episodic and chronic migraine: a controlled study.
PPT is decreased in women with migraine relative to controls, and future studies should explore this parameter as a biological marker of the disease and a predictor of treatment. Expand
Interaction among nitric oxide (NO)-related genes in migraine susceptibility
A significant interaction is found between eNOS rs743506 and iNOS2087G/A polymorphisms in migraine patients compared to control group (P < 0.05), suggesting that this combination affect the susceptibility to migraine. Expand
Intravenous Dipyrone in the Acute Treatment of Migraine Without Aura and Migraine with Aura: A Randomized, Double Blind, Placebo Controlled Study
Background.— Dipyrone (Metamizol) has been used in the acute treatment of migraines in Brazil. Some investigators have found it to be a highly effective medication for migraine pain and associatedExpand